Transplantation and Changing Management of Organ Failure

1: Past and future alternatives and strategies.- 1. Trends in the epidemiology of end-stage renal disease over the last decade.- 2. Answers to liver graft shortage: hepatocyte transplantation and bioartificial liver.- 3. Enzymatic and biochemical substitutes to organ transplantation in inborn errors of metabolism.- 4. Tolerance induction.- 5. Xenotransplantation: immunological advances.- 2: Liver replacement therapy.- 6. Living donor in liver transplantation as novel graft source.- 7. Ex-situ liver support.- 3: Renal replacement therapy.- 8. Preventing end-stage renal disease: fact or fiction?.- 9. Transplantation and short daily haemodialysis.- 10. Comparison of survival probabilities between renal transplant recipients and patients undergoing regular dialysis: a single centre prospective study.- 11. Transplantation versus dialysis in aged and type II diabetic patients.- 4: Pancreas replacement therapy.- 12. External and implantable insulin pumps: current place in the treatment of diabetes.- 13. Pancreas and islet transplantation in the treatment of type I diabetes.- 14. Perspectives in early detection and management of IDDM.- 5: Heart and lung replacement therapy.- 15. Mechanical circulatory support: today’s facts and future horizons.- 16. Intra-myocardial myoblast injection.- 17. Ambulatory management of primary pulmonary hypertension.- 18. Cystic fibrosis: conservative management.- 6: Emerging transplantations and management.- 19. Intestinal transplantation.- 20. Intracerebral grafting of fetal neuroblasts for neurodegenerative diseases: experimental bases and clinical results.- 21. Skin equivalents.- 7: Concluding remarks.- 22. Public health issues from European countries.- 23. Clinical evaluation of organ transplantation in France.- 24. From Lyon to Louisville:the need for tolerance.- Name index.